With the Chalk River* nuclear reactor in Laurentian Hills, Ontario, Canada, shutdown, a reactor that supplies one-third** of the nuclear isotopes to the world, it was very timely when Canadian Prime Minister Stephen Harper welcomed the SNM annual meeting to Toronto, Canada, emphasizing the importance of molecular imaging to the future practice of medicine.
While the reactor is down for an undetermined amount of time, patients in North America requiring nuclear medicine procedures for diagnosing cancer, and neurological and cardiovascular diseases will face serious delays in medical treatment. As such, the medical isotope crisis places unprecedented importance on the SNM Annual Meeting, which called a press conference to address the issue: “Current Developments in the Medical Isotope Crisis and Molecular Imaging Research Breakthroughs,” on Monday, June 15, 11:30 a.m. to 12:45 p.m., in room 810 of the convention center.
The panel of top molecular imaging researchers, in addition to SNM President Robert W. Atcher, Ph.D, M.B.A., President-Elect Michael M. Graham, M.D., Ph.D, Peter S. Conti, M.D., Ph.D, and Henry N. Wagner, Jr., M.D., Johns Hopkins University, will discuss the latest developments surrounding the international medical isotope crisis; and announce major molecular imaging breakthroughs in the detection and treatment of cancers, heart and brain diseases.
Imaging Technology News – June 12, 2009.